This approach, utilizing both blood and tumor tissue analysis, will enable a more nuanced comprehension of DYRK3’s role in oral squamous cell carcinoma and may contribute to the identification of novel diagnostic markers, prognostic indicators, or therapeutic targets for this particular type of cancer. The gene discussed is DYRK3; the disease is cancer.